5 results match your criteria: "Hyderabad Rheumatology Centre[Affiliation]"
Myositis India: Early lessons from a patient support group in a resource-limited setting.
Int J Rheum Dis
September 2024
Division of Rheumatology and Clinical Immunology, Arthritis and Autoimmunity Center and UPMC Myositis Center, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Tocilizumab in Recalcitrant Bilateral Scleritis in a Case of Relapsing Polychondritis: A 17-year Follow Up.
Ocul Immunol Inflamm
May 2023
Department of Rheumatology, Nizams Institute of Medical Services, Hyderabad, India.
Article Synopsis
- A 36-year-old woman was diagnosed with relapsing polychondritis after experiencing symptoms like scleritis and saddle nose deformity over a 17-year period.
- Her condition showed only partial improvement despite various treatments, including corticosteroids and immunosuppressants.
- Tocilizumab, a newer medication, was introduced in 2017, leading to significant stabilization of both her systemic and ocular symptoms for the last four years.
Tumoral calcinosis in a patient with chronic renal failure.
J R Coll Physicians Edinb
March 2021
Hyderabad Rheumatology Centre, Begumpet, Hyderabad-500016, India.
Deficiency of Adenosine Deaminase 2 in Adults and Children: Experience From India.
Arthritis Rheumatol
February 2021
Boston Children's Hospital, Massachusetts.
Objective: Deficiency of adenosine deaminase 2 (DADA2) is a potentially fatal monogenic syndrome characterized by variable manifestations of systemic vasculitis, bone marrow failure, and immunodeficiency. Most cases are diagnosed by pediatric care providers, given the typical early age of disease onset. This study was undertaken to describe the clinical phenotypes and treatment response both in adults and in children with DADA2 in India.
View Article and Find Full Text PDFImpact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India.
Ann Rheum Dis
May 2021
Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.